Myomo MYO
NYSE MYO
$1.33 -0.01 (-0.75%)
As of: Sep 9, 2026 · 3:59 PM EDT

Myomo (MYO) Change in Accured Expenses (2016 - 2025)

Myomo's (MYO) quarterly Change in Accured Expenses came in at -$1.4 million in Q3 2025, down 251.21% on a YoY basis from $904822.0 in Q3 2024, and up 30.62% quarter-over-quarter from -$2.0 million in Q2 2025.

Analysis

Myomo (MYO) Change in Accured Expenses (2016 - 2025) Analysis & Trends

Myomo (MYO) has reported Change in Accured Expenses for 10 consecutive years, with -$1.4 million the latest figure, recorded in Q3 2025.

  • For the quarter ending Q3 2025, Change in Accured Expenses fell 251.21% year-over-year to -$1.4 million; the trailing twelve-month figure through Sep 2025 stood at $897995.0 (down 41.84% YoY), and the FY2024 full-year result was $4.7 million, up 162.17% from the prior year.
  • Change in Accured Expenses rose to -$1.4 million in Q3 2025 per MYO's latest filing, from -$2.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $2.8 million in Q4 2024 and bottomed at -$2.0 million in Q2 2025.
  • Historically, Change in Accured Expenses has averaged $262382.1 across 5 years, with a median of $386880.0 in 2023.
  • The widest YoY moves for Change in Accured Expenses: up 1555.4% in 2025, down 318.16% in 2025.
  • Over 5 years, Change in Accured Expenses stood at $535997.0 in 2021, then sank by 183.53% to -$447716.0 in 2022, then climbed by 21.41% to -$351845.0 in 2023, then surged by 895.05% to $2.8 million in 2024, then plunged by 148.91% to -$1.4 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered -$1.4 million, -$2.0 million, and $1.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 55.00 Mn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn -531.00 Mn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 298.00 Mn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 234.00 Mn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 123.70 Mn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -74.00 Mn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 112.90 Mn
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 4.80 Mn
10 Myomo 54.96 Mn 35.99 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -1.37 Mn
Jun 30, 2025 -1.97 Mn
Mar 31, 2025 1.44 Mn
Dec 31, 2024 2.80 Mn
Sep 30, 2024 904,822.00
Jun 30, 2024 903,932.00
Mar 31, 2024 87,041.00
Dec 31, 2023 -351,845.00
Sep 30, 2023 1.25 Mn
Jun 30, 2023 501,714.00
Mar 31, 2023 386,880.00
Dec 31, 2022 -447,716.00
Sep 30, 2022 278,415.00
Jun 30, 2022 -837,425.00
Mar 31, 2022 294,828.00
Dec 31, 2021 535,997.00
Sep 30, 2021 559,312.00
Jun 30, 2021 -934,413.00
Mar 31, 2021 952,339.00
Dec 31, 2020 723,618.00